Ngā hua rapu - David Dankort
- E whakaatu ana i te 1 - 19 hua o te 19
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer mā David Dankort, Bart M. Maślikowski, Neil Warner, Nubufumi Kanno, Harold Kim, Zhixiang Wang, Michael F. Moran, Robert G. Oshima, Robert D. Cardiff, William J. Muller
I whakaputaina 2001Artigo -
12
-
13
RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage mā Zubaidah M. Ramdzan, Charles Vadnais, Ranjana Pal, Guillaume Vandal, Chantal Cadieux, Lam Leduy, Sayeh Davoudi, Laura Hulea, Lu Yao, Anthony N. Karnezis, Marilène Paquet, David Dankort, Alain Nepveu
I whakaputaina 2014Artigo -
14
β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas mā William Damsky, David P. Curley, Manjula Santhanakrishnan, Lara E. Rosenbaum, James T. Platt, Bonnie E. Gould Rothberg, Makoto M. Taketo, David Dankort, David L. Rimm, Martin McMahon, Marcus Bosenberg
I whakaputaina 2011Artigo -
15
Abrogation of BRAF<sup>V600E</sup>-induced senescence by PI3K pathway activation contributes to melanomagenesis mā Liesbeth C.W. Vredeveld, Patrícia A. Possik, Marjon A. Smit, Katrin Meissl, Chrysiis Michaloglou, Hugo M. Horlings, Abderrahim Ajouaou, Pim Kortman, David Dankort, Martin McMahon, Wolter J. Mooi, Daniel S. Peeper
I whakaputaina 2012Artigo -
16
B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer mā Jingqiang Wang, Takashi Kobayashi, Nicolas Floc’h, Carolyn Waugh Kinkade, Àlvaro Aytés, David Dankort, Céline Lefèbvre, Antonina Mitrofanova, Robert D. Cardiff, Martin McMahon, Andrea Califano, Michael M. Shen, Cory Abate‐Shen
I whakaputaina 2012Artigo -
17
A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma mā Eric A. Collisson, Christy L. Trejo, Jillian M. Silva, Shenda Gu, James E. Korkola, Laura M. Heiser, Roch‐Philippe Charles, Brian Rabinovich, Byron Hann, David Dankort, Paul T. Spellman, Wayne A. Phillips, Joe W. Gray, Martin McMahon
I whakaputaina 2012Artigo -
18
mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation mā William Damsky, Goran Micevic, Katrina Meeth, Viswanathan Muthusamy, David P. Curley, Manjula Santhanakrishnan, Ildikó Erdélyi, James T. Platt, Laura C. Huang, Nicholas Theodosakis, M. Raza Zaidi, Scott Tighe, Michael A. Davies, David Dankort, Martin McMahon, Glenn Merlino, Nabeel Bardeesy, Marcus Bosenberg
I whakaputaina 2015Artigo -
19
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses mā Fan Huang, Christophe Gonçalves, Margarita Bartish, Joelle Rémy-Sarrazin, Mark E. Issa, Brendan Cordeiro, Qianyu Guo, Audrey Émond, Mikhaël Attias, William Yang, Dany Plourde, Jie Su, Marina Godoy Gimeno, Zhan Yao, Alba Galán, Tomasz Rzymski, Milena Mazan, Magdalena Masiejczyk, Jacek Faber, Elie Khoury, Alexandre Benoît, Natascha Gagnon, David Dankort, Fabrice Journé, Ghanem E. Ghanem, Connie M. Krawczyk, H. Uri Saragovi, Ciriaco A. Piccirillo, Nahum Sonenberg, Ivan Topisirović, Christopher E. Rudd, Wilson H. Miller, Sonia V. del Rincón
I whakaputaina 2021Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Cancer research
Genetics
Cell biology
Gene
Cancer
Signal transduction
Medicine
Melanoma
Molecular biology
PI3K/AKT/mTOR pathway
Carcinogenesis
Internal medicine
Mutation
Receptor tyrosine kinase
Biochemistry
Cell cycle
MAPK/ERK pathway
Oncogene
PTEN
Protein kinase B
Receptor
Tyrosine kinase
Cell
ErbB
KRAS
Breast cancer
DNA
DNA damage
DNA repair